Close

Analyst Ratings for PDL BioPharma (PDLI) [Neutrals]

PDLI Rating Summary

  |   Expand Research on PDLI
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/3/2013 Janney N/A New Coverage Neutral
(N/A)
7.00
(N/A)
7.34
(2.47)
-66.35% Details
8/24/2012 ThinkEquity N/A New Coverage Hold
(N/A)
7.00
(N/A)
7.33
(2.47)
-66.3% Details